A simple urine test for the virus that causes cervical cancer could offer a less invasive and more acceptable alternative to the conventional cervical smear test, researchers said on Tuesday.

Cervical cancer is highly preventable with routine screening. To provide people with a cervix a comfortable and private ...

Many women assume that their annual gynecological exam automatically includes a Pap smear test. But new guidelines suggesting that a Pap test every three to five years is best will likely change ...

(Medical Xpress) -- Testing for the human papillomavirus (HPV) – a virus most women will encounter at some point in their lives – followed by a smear test if they are HPV positive, provides ...

Women now have an alternative to the Pap smear as a screening test for cervical cancer. The U.S. Food and Drug Administration on Friday approved an at-home screening test. As Reuters reported, Pap ...

HPV test may be better than Pap smears at detecting early cervical cancer: Study Dr. Ashton discusses what to know about the stunning new study that says HPV blood tests were more likely to detect ...

While a smear test isn't exactly the most inviting way to spend a small proportion of your day once every three years, most of us go to them anyway. Why? Because despite the fact it requires you ...

A small study shows that self-collected vaginal or urine samples can be used to detect precancerous cervical lesions, and could eventually replace the Pap 'smear' test.

A test for HPV detects precancerous changes of the cervix earlier and more accurately than the Pap smear, according to a large clinical trial published Tuesday.

There's no sugar coating it - having a cervical smear test is right up there with the likes of getting chilli in your eye or accidentally putting a kiss on the end of an email to your boss ...

In 2012, I was shocked to learn that new guidelines issued by the The American College of Obstetricians and Gynecologists stated that women should wait three to five years between pap smears ...

WASHINGTON (AP) — U.S. government health regulators have cleared a genetic test from Roche as a first-choice screening option for cervical cancer. It was a role previously reserved for the Pap ...